Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07830979

Hydrogen Peroxide 40% Versus Salicylic Acid 40% for Plantar Warts

This randomized controlled trial aims to compare the efficacy and safety of topical hydrogen peroxide 40 percent versus topical salicylic acid 40 percent in the treatment of plantar warts.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

12 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

About this study

Plantar warts are common benign lesions caused by human papillomavirus on weight-bearing areas causing pain and functional impairment. This is a randomized parallel assignment study conducted at the Outpatient Dermatology Clinic Assiut University Hospital. Eligible patients with clinically diagnosed plantar warts will be randomized in 1 to 1 ratio to topical hydrogen peroxide 40 percent applied once weekly by physician or topical salicylic acid 40 percent self-applied once daily. Treatment duration 12 weeks with assessments every 2 weeks including measurement size photographs clearance status adverse effects compliance and satisfaction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age greater than or equal to 12 years of both sexes
  • Clinically diagnosed plantar wart or warts
  • Wart duration at least 2 weeks prior to enrollment
  • Willing and able to give written informed consent or parental consent for minors
  • Able to attend follow-up visits and comply with home-application protocol

Exclusion criteria

  • Pregnant or lactating women
  • Immunocompromised patients including HIV infection organ transplant recipients or on immunosuppressive therapy
  • Diabetic patients with peripheral neuropathy or peripheral arterial disease
  • Known hypersensitivity to hydrogen peroxide or salicylic acid
  • Received any topical or systemic wart treatment within preceding 4 weeks
  • Clinically atypical lesions raising suspicion of malignancy
  • Active local skin infection or open wound at treatment site
  • Unable or unwilling to complete follow-up schedule

Treatment and study plan

Hydrogen Peroxide 40%

Drug

Topical hydrogen peroxide 40 percent w/w solution in opaque light-protected applicator bottle applied once weekly for up to 12 weeks

Salicylic Acid 40%

Drug

Topical salicylic acid 40 percent w/w preparation applied once daily for up to 12 weeks

Primary outcomes

  1. Number of participants with complete clinical clearance

    Time frame: At 12 weeks

    Number of participants with complete clinical clearance defined as complete disappearance of plantar wart and restoration of normal skin markings

Secondary outcomes

  1. Time to complete clearance

    Time frame: Up to 12 weeks

    Time in weeks from treatment start to complete clinical clearance

  2. Change in wart surface area

    Time frame: From baseline to 12 weeks

    Change in wart surface area in square millimeters measured in two perpendicular diameters using digital caliper from baseline

  3. Treatment-related pain score

    Time frame: Up to 12 weeks

    Pain score assessed using 0 to 10 Visual Analogue Scale with 0 indicating no pain and 10 indicating worst pain with higher scores indicating worse pain

  4. Number of participants with local adverse effects

    Time frame: Up to 12 weeks

    Number of participants who develop local adverse effects including blistering hyperpigmentation scarring or secondary infection

  5. Patient satisfaction score

    Time frame: At 12 weeks

    Patient satisfaction assessed using 0 to 10 satisfaction scale with higher scores indicating greater satisfaction

  6. Number of participants with recurrence

    Time frame: Up to 12 weeks

    Number of participants with recurrence of plantar warts after initial complete clearance

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed A Abdel rady, Resident

CONTACT

[email protected]

01024907721

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Topical Hydrogen Peroxide 40% Versus Salicylic Acid 40% in the Treatment of Plantar Warts: A Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Sep 21, 2026
Registry last updated
Sep 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.